Interim Director Caryn Lerman, PhD Discusses the Abramson Cancer Center

Caryn Lerman, PhD, is the Interim Director of Penn Medicine's Abramson Cancer Center. Dr. Lerman discusses the innovative and unique aspects of the Abramson Cancer Center.

Learn more at http://www.pennmedicine.org/abramson

Here at the Abramson Cancer Center, we have all of the specialist under one roof so that a patient can meet with their radiation oncologist, their medical oncologist, surgical oncologist as well as the patient's services
coordinators who can address all of their medical, emotional and personal needs at one time in one place.

Cancer treatment is not a one size fits all model. Here at the Abramson Cancer Center, treatments are targeted to the individual genetic characteristics of the patient as well as the characteristics of their condition.

Our scientists and clinicians work very closely together so that we can ensure that the latest scientific discoveries are being translated to cancer care.

When a patient comes to the Abramson Cancer Center, they know that they are receiving the optimal cancer care that is targeted to their own individual characteristics and personal needs.

We offer all of the latest clinical trials for testing novel therapies and novel ways to deliver therapies so patients can learn from their health care providers and nurses at the trial that would be optimal for their particular
condition.

Recently, we completed our National Cancer Institute renewal of the cancer center where we were rated as exceptional among all of our peer institutions.

The best way to protect yourself is by gathering as much information as you can so we urge you to use this information and our website to learn more about cancer prevention and treatment and survivorship services at
the Abramson Cancer Center.